Townsquare Capital LLC Abb Vie Inc. Transaction History

Townsquare Capital LLC

$7.19 Billion
Q2 2024

A detailed history of Townsquare Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Townsquare Capital LLC holds 138,315 shares of ABBV stock, worth $27.3 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

138,315

Previous 102,196 35.34%

Holding current value

$27.3 Million

Previous $18.6 Million 27.48%

% of portfolio

0.33%

Previous 0.28%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $5.59 Million - $6.53 Million	36,119 Added 35.34%	138,315 $23.7 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $446,057 - $508,241	-2,791 Reduced 2.66%	102,196 $18.6 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $1.14 Million - $1.28 Million	-8,255 Reduced 7.29%	104,987 $16.3 Million
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $602,223 - $697,162	-4,508 Reduced 3.83%	113,242 $16.9 Million
Q2 2023 Nov 13, 2023	BUY	$132.51 - $164.9 $2.28 Million - $2.84 Million	17,223 Added 17.13%	117,750 $15.9 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $778,724 - $896,817	-5,385 Reduced 5.08%	100,527 $16 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $5.71 Million - $6.84 Million	41,263 Added 63.83%	105,912 $17.1 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $296,738 - $340,339	2,211 Added 3.54%	64,649 $8.68 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $517,588 - $658,024	3,761 Added 6.41%	62,438 $9.56 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $917,392 - $1.14 Million	6,951 Added 13.44%	58,677 $9.51 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $94,216 - $119,210	-877 Reduced 1.67%	51,726 $7 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $779,912 - $885,317	7,330 Added 16.19%	52,603 $5.68 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $315,630 - $351,630	3,000 Added 7.1%	45,273 $5.24 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $23,938 - $26,353	234 Added 0.56%	42,273 $4.57 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.29 Million - $1.74 Million	16,016 Added 61.55%	42,039 $4.5 Million
Q3 2020 Dec 01, 2020	BUY	$85.91 - $100.83 $57,130 - $67,051	665 Added 2.62%	26,023 $2.24 Million
Q2 2020 Aug 17, 2020	SELL	$73.37 - $98.18 $519,753 - $695,507	-7,084 Reduced 21.84%	25,358 $2.48 Million
Q1 2020 May 18, 2020	BUY	$64.5 - $97.79 $210,979 - $319,871	3,271 Added 11.21%	32,442 $2.69 Million
Q4 2019 May 18, 2020	SELL	$72.13 - $90.25 $228,002 - $285,280	-3,161 Reduced 9.78%	29,171 $2.58 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $89,872 - $108,052	1,427 Added 4.62%	32,332 $2.65 Million
Q2 2019 Aug 15, 2019	SELL	$65.7 - $83.98 $599,184 - $765,897	-9,120 Reduced 22.79%	30,905 $2.02 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.18 Million - $1.39 Million	15,331 Added 62.08%	40,025 $3.23 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $1.92 Million - $2.37 Million	24,694 New	24,694 $1.97 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Account

Townsquare Capital LLC Abb Vie Inc. Transaction History